Work

PMDA Perspective on RWD / RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage

Year: 2024

Type: article

Source: Pharmacoepidemiology and Drug Safety

DOI: 10.1002/pds.70007

Authors: Kazuhiro Kajiyama, Maki Komamine, Naoya Horiuchi, Toyotaka Iguchi, Yoshiaki Uyama

Institution: Pharmaceuticals and Medical Devices Agency

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,430

OpenAlex ID: W4402319178

FWCI: 7.725

Cites: 11

Cited by: 10

Related to: 10